INNOVIN Trademark

Trademark Overview

On Friday, January 15, 1993, a trademark application was filed for INNOVIN with the United States Patent and Trademark Office. The USPTO has given the INNOVIN trademark a serial number of 74348661. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, July 9, 2024. This trademark is owned by Baxter Diagnostics Inc.. The INNOVIN trademark is filed in the Chemical Products category with the following description:

lyophilized recombinant human tissue factor combined with phospholipids, calcium, buffers and stabilizers for diagnostic use
innovin

General Information

Serial Number74348661
Word MarkINNOVIN
Filing DateFriday, January 15, 1993
Status800 - REGISTERED AND RENEWED
Status DateTuesday, July 9, 2024
Registration Number1837316
Registration DateTuesday, May 24, 1994
Mark Drawing1 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, December 21, 1993

Trademark Statements

Goods and Serviceslyophilized recombinant human tissue factor combined with phospholipids, calcium, buffers and stabilizers for diagnostic use

Classification Information

International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes006
Class Status Code6 - Active
Class Status DateWednesday, March 17, 1993
Primary Code001
First Use Anywhere DateFriday, October 30, 1992
First Use In Commerce DateFriday, October 30, 1992

Trademark Owner History

Party NameSIEMENS HEALTHCARE DIAGNOSTICS INC.
Party Type41 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressTarrytown, NY 10591
Party NameDADE BEHRING INC.
Party Type40 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressDEERFIELD, IL 60015
Party NameBaxter Diagnostics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter Diagnostics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015
Party NameBaxter Diagnostics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressDeerfield, IL 60015

Trademark Events

Event DateEvent Description
Monday, April 5, 1993APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 2, 1993ASSIGNED TO EXAMINER
Tuesday, June 1, 1993NON-FINAL ACTION MAILED
Wednesday, September 1, 1993CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, November 24, 1993NOTICE OF PUBLICATION
Tuesday, December 21, 1993PUBLISHED FOR OPPOSITION
Monday, May 15, 2000REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Monday, May 24, 2004REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Monday, May 17, 1993PREVIOUS ALLOWANCE COUNT WITHDRAWN
Monday, September 27, 1993APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, May 24, 1994REGISTERED-PRINCIPAL REGISTER
Thursday, August 24, 2000REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Monday, August 23, 2004REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Monday, August 23, 2004REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Wednesday, February 20, 2008ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Tuesday, April 6, 2010CASE FILE IN TICRS
Friday, April 18, 2014REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
Thursday, July 29, 2004POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Friday, August 20, 2004FAX RECEIVED
Tuesday, April 15, 2014TEAS SECTION 8 & 9 RECEIVED
Tuesday, April 15, 2014REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
Friday, April 18, 2014REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, April 9, 2024TEAS SECTION 8 & 9 RECEIVED
Tuesday, July 9, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Friday, April 18, 2014NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Wednesday, May 24, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Tuesday, July 9, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 9, 2024REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Tuesday, July 9, 2024REGISTERED AND RENEWED (THIRD RENEWAL - 10 YRS)

Related Keywords

innovin calcium buffers stabilizers diagnostic phospholipids combined recombinant human tissue factor